Stock listing
Lang & Schwarz:A40ZAV MiNK Therapeutics, Inc. Aktie
German listing (Lang & Schwarz) of MiNK Therapeutics, Inc. · home listing NASDAQ:INKT
Follow MiNK Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:INKT
$11.04 USD +0.51 (+4.8%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:INKT
- Day range
- $10.41 – $11.48 USDNov 2, 2026
- Volume
- 11,511 sharesNov 2, 2026
- Market cap
- $56.34M USDAt the close on Nov 2, 2026 · price × 5.10M shares outstanding
- 52-week range
- $8.48 – $16.93 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $164,283 USDMedian day 10,600 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:INKT · Home | $11.04 USD | +0.51 (+4.8%) | 11,511 | $10.41 | $11.48 | $10.41 | $10.53 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:INKT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $11.04 | +0.51 | +4.8% | $10.41 | $11.48 | $10.41 | 11,511 | |
| $10.53 | -0.345 | -3.2% | $10.55 | $10.64 | $10.35 | 8,681 | |
| $10.88 | +0.075 | +0.7% | $11.13 | $11.13 | $10.41 | 9,625 | |
| $10.80 | +0.17 | +1.6% | $10.76 | $11.13 | $10.76 | 6,131 | |
| $10.63 | +0.20 | +1.9% | $10.48 | $10.85 | $10.41 | 10,120 | |
| $10.43 | -0.28 | -2.6% | $10.75 | $11.40 | $10.43 | 13,291 | |
| $10.71 | +0.65 | +6.5% | $10.64 | $11.68 | $10.18 | 29,400 | |
| $10.06 | -0.56 | -5.3% | $10.65 | $10.65 | $10.06 | 9,800 | |
| $10.62 | +0.76 | +7.7% | $9.80 | $10.99 | $9.80 | 18,600 | |
| $9.86 | +0.30 | +3.1% | $9.31 | $9.97 | $9.19 | 8,400 | |
| $9.56 | +0.15 | +1.6% | $9.61 | $9.68 | $9.25 | 14,100 | |
| $9.41 | -0.53 | -5.3% | $9.87 | $10.10 | $9.38 | 13,600 | |
| $9.94 | -0.41 | -4.0% | $10.35 | $10.35 | $9.934 | 10,100 | |
| $10.35 | +0.12 | +1.2% | $10.17 | $10.35 | $10.09 | 6,000 | |
| $10.23 | -0.30 | -2.8% | $10.44 | $10.65 | $10.12 | 7,200 | |
| $10.53 | -0.19 | -1.8% | $10.90 | $11.24 | $10.36 | 18,800 | |
| $10.72 | -0.28 | -2.5% | $10.96 | $10.96 | $10.68 | 17,000 | |
| $11.00 | -0.42 | -3.7% | $11.56 | $11.56 | $10.96 | 10,600 | |
| $11.42 | -0.28 | -2.4% | $11.63 | $11.63 | $11.32 | 13,800 | |
| $11.70 | -0.50 | -4.1% | $12.11 | $12.20 | $11.63 | 33,000 | |
| $12.20 | -0.24 | -1.9% | $12.51 | $12.84 | $12.10 | 28,600 | |
| $12.44 | -0.29 | -2.3% | $12.72 | $12.72 | $12.10 | 48,900 | |
| $12.73 | +0.18 | +1.4% | $12.71 | $12.96 | $12.49 | 26,700 | |
| $12.55 | +0.29 | +2.4% | $12.62 | $12.98 | $12.19 | 61,100 | |
| $12.26 | +0.15 | +1.2% | $12.18 | $12.59 | $12.09 | 20,200 | |
| $12.11 | -0.07 | -0.6% | $11.82 | $12.44 | $11.72 | 13,700 | |
| $12.18 | -0.12 | -1.0% | $12.00 | $12.46 | $11.70 | 11,500 | |
| $12.30 | -0.05 | -0.4% | $12.36 | $12.42 | $11.75 | 10,000 | |
| $12.35 | +0.24 | +2.0% | $12.50 | $12.50 | $11.68 | 14,800 | |
| $12.11 | -0.14 | -1.1% | $12.14 | $12.38 | $11.50 | 8,600 | |
| $12.25 | +0.20 | +1.7% | $11.84 | $12.69 | $11.57 | 8,000 | |
| $12.05 | +0.34 | +2.9% | $12.00 | $12.08 | $11.70 | 18,600 | |
| $11.71 | +0.12 | +1.0% | $11.58 | $12.00 | $11.47 | 3,600 | |
| $11.59 | +0.18 | +1.6% | $11.47 | $11.68 | $11.31 | 4,800 | |
| $11.41 | -0.56 | -4.7% | $11.70 | $11.70 | $11.40 | 15,800 | |
| $11.97 | -0.03 | -0.2% | $12.25 | $12.41 | $11.75 | 55,900 | |
| $12.00 | -0.13 | -1.1% | $12.17 | $12.48 | $11.90 | 42,400 | |
| $12.13 | +0.23 | +1.9% | $12.69 | $12.69 | $12.00 | 22,400 | |
| $11.90 | +0.45 | +3.9% | $11.54 | $12.16 | $11.54 | 16,800 | |
| $11.45 | -0.19 | -1.6% | $11.61 | $11.85 | $11.45 | 11,000 | |
| $11.64 | +0.41 | +3.7% | $11.16 | $11.64 | $11.16 | 5,800 | |
| $11.23 | -0.10 | -0.9% | $11.08 | $11.54 | $11.08 | 3,200 | |
| $11.33 | +0.38 | +3.5% | $11.00 | $11.42 | $10.82 | 8,300 | |
| $10.95 | -0.14 | -1.3% | $11.02 | $11.35 | $10.95 | 2,200 | |
| $11.09 | -0.338 | -3.0% | $11.51 | $11.75 | $10.95 | 11,900 | |
| $11.43 | -0.252 | -2.2% | $11.33 | $11.45 | $11.06 | 6,900 | |
| $11.68 | -0.11 | -0.9% | $11.60 | $11.80 | $11.46 | 4,700 | |
| $11.79 | +0.41 | +3.6% | $11.29 | $11.79 | $11.29 | 9,000 | |
| $11.38 | -0.44 | -3.7% | $11.26 | $11.80 | $11.04 | 9,400 | |
| $11.82 | -0.38 | -3.1% | $12.24 | $12.24 | $11.51 | 8,100 | |
| $12.20 | +0.58 | +5.0% | $11.64 | $12.20 | $11.22 | 11,800 | |
| $11.62 | +0.49 | +4.4% | $11.10 | $11.70 | $10.98 | 11,300 | |
| $11.13 | -0.87 | -7.2% | $11.84 | $12.09 | $11.00 | 14,500 | |
| $12.00 | +0.78 | +7.0% | $11.01 | $12.00 | $11.01 | 10,600 | |
| $11.22 | -0.05 | -0.4% | $11.15 | $11.49 | $11.06 | 7,800 | |
| $11.27 | +0.27 | +2.5% | $11.10 | $11.50 | $10.95 | 6,800 | |
| $11.00 | -0.36 | -3.2% | $11.29 | $11.32 | $10.82 | 8,600 | |
| $11.36 | +0.13 | +1.2% | $11.06 | $11.60 | $11.06 | 4,700 | |
| $11.23 | +0.28 | +2.6% | $10.95 | $11.56 | $10.95 | 5,900 | |
| $10.95 | 0.00 | 0.0% | $10.96 | $10.96 | $10.80 | 5,100 | |
| $10.95 | -0.05 | -0.5% | $10.90 | $11.57 | $10.89 | 4,700 | |
| $11.00 | -0.70 | -6.0% | $11.70 | $11.97 | $11.00 | 18,800 | |
| $11.70 | +0.63 | +5.7% | $11.15 | $11.70 | $11.00 | 15,100 | |
| $11.07 | +0.38 | +3.6% | $10.70 | $11.38 | $10.68 | 10,600 | |
| $10.69 | +0.19 | +1.8% | $10.48 | $10.75 | $10.48 | 5,600 |
- Ticker
- Lang & Schwarz:A40ZAV
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Nov 2, 2026
MiNK Therapeutics to Report Third Quarter 2026 Results and Outline Progress in Randomized Clinical Development and Scalable iNKT Cell Therapy
Latest earnings call · Aug 13, 2026
Mink Therapeutics (NASDAQ:INKT) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 13, 2026
Q2 2026 Earnings Presentation
Earnings · 15 slides
Calls
Upcoming
Mink Therapeutics (NASDAQ:INKT) Q3 2026 Earnings Call
Wed, Nov 11, 2026 · 8:30 AM ET
Register
Replays
Mink Therapeutics (NASDAQ:INKT) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 8:30 AM ET
Watch TranscriptMink Therapeutics (NASDAQ:INKT) Q1 2026 Earnings Call
Fri, May 15, 2026 · 8:30 AM ET
Watch TranscriptMink Therapeutics (NASDAQ:INKT) Q4 2025 Earnings Call
Tue, Mar 31, 2026 · 8:30 AM ET
Watch Transcript
Latest news
MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026
Oct 2, 2026
Closed $12.44 (-2.3%) on Oct 2, 2026
MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy
Sep 30, 2026
Closed $12.55 (+2.4%) on Sep 30, 2026
MiNK Therapeutics Reports Second Quarter 2026 Financial Results and Reports Observations from Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury
Aug 13, 2026
Closed $11.00 (-3.2%) on Aug 13, 2026
MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates
Aug 6, 2026
Closed $11.00 (-6.0%) on Aug 6, 2026
MiNK Therapeutics Announces its Virtual 2026 Annual Shareholders Meeting
Jun 3, 2026
Closed $12.75 (-0.1%) on Jun 4, 2026
MiNK Therapeutics Announces First Patient Dosed in Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness
May 28, 2026
Closed $12.20 (+19.8%) on May 28, 2026
MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications
May 20, 2026
Closed $10.72 (+3.6%) on May 20, 2026
MiNK Therapeutics Reports First Quarter 2026 Financial Results and Advances iNKT Cell Therapy Platform Into Randomized Clinical Validation
May 15, 2026
Closed $10.72 (+2.0%) on May 15, 2026
MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therapy Programs
May 8, 2026
Closed $10.95 (-0.8%) on May 11, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 15 slides · Aug 13, 2026
Technical Presentation (February 2025)
Technical · 12 slides · February 2025
Investor Day (November 2022)
Investor day · 92 slides · Nov 10, 2022
MiNK Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 24 in the last 12 months · 85 in all · newest Nov 2, 2026 · oldest 2021
- Calls
- 16 calls with a replay · 16 with a transcript · latest Aug 13, 2026
- Decks
- 3 decks · latest Aug 13, 2026
Where MiNK Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:INKT · Home listing | NASDAQ | United States | USD |
| Lang & Schwarz:A40ZAV · This page | Lang & Schwarz | Germany | EUR |
| LS Exchange:A40ZAV | LS Exchange | Germany | EUR |
| BOATS:INKT | BOATS | United States | USD |
| gettex:6Q40 | gettex | Germany | EUR |
| Frankfurt:6Q40 | Frankfurt | Germany | EUR |
| Munich:6Q40 | Munich | Germany | EUR |
| Tradegate:6Q40 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about MiNK Therapeutics, Inc.